12/23
04:09 pm
achv
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/17
04:55 pm
achv
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week [Yahoo! Finance]
Medium
Report
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week [Yahoo! Finance]
12/17
04:11 pm
achv
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week
Medium
Report
Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week
12/8
04:10 pm
achv
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Low
Report
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
11/29
07:19 am
achv
Institutions profited after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap rose US$48m last week but individual investors profited the most [Yahoo! Finance]
Medium
Report
Institutions profited after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap rose US$48m last week but individual investors profited the most [Yahoo! Finance]
11/25
08:41 am
achv
Achieve Life Sciences (NASDAQ:ACHV) is now covered by analysts at Citizens Jmp. They set a "market outperform" rating and a $19.00 price target on the stock.
High
Report
Achieve Life Sciences (NASDAQ:ACHV) is now covered by analysts at Citizens Jmp. They set a "market outperform" rating and a $19.00 price target on the stock.
11/25
05:04 am
achv
Achieve Life Sciences (NASDAQ:ACHV) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
High
Report
Achieve Life Sciences (NASDAQ:ACHV) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
11/24
07:02 am
achv
Achieve Life Sciences (NASDAQ:ACHV) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Medium
Report
Achieve Life Sciences (NASDAQ:ACHV) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
11/12
01:23 pm
achv
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/10
09:37 am
achv
ACHV: FDA's CNPV Awarded for Vaping [Yahoo! Finance]
Low
Report
ACHV: FDA's CNPV Awarded for Vaping [Yahoo! Finance]
11/7
01:12 am
achv
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
07:17 am
achv
Achieve Life Sciences GAAP EPS of -$0.28 misses by $0.02 [Seeking Alpha]
Low
Report
Achieve Life Sciences GAAP EPS of -$0.28 misses by $0.02 [Seeking Alpha]
11/6
07:00 am
achv
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
Medium
Report
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
11/3
08:30 am
achv
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
Low
Report
Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation
10/29
08:30 am
achv
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
Medium
Report
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025
10/20
08:30 am
achv
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
High
Report
Achieve Life Sciences Appoints Erik Atkisson as Chief Legal Officer
10/19
09:41 am
achv
Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Expedites Review of Vaping Cessation Therapy - What's Changed [Yahoo! Finance]
High
Report
Achieve Life Sciences (ACHV) Is Up 36.4% After FDA Expedites Review of Vaping Cessation Therapy - What's Changed [Yahoo! Finance]
10/18
10:11 pm
achv
A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy [Yahoo! Finance]
High
Report
A Look at Achieve Life Sciences's Valuation After FDA Priority Voucher for Cytisinicline Therapy [Yahoo! Finance]
10/17
07:30 am
achv
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
High
Report
Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher for Cytisinicline for Treatment of Nicotine Dependence for E-cigarette or Vaping Cessation
10/3
02:37 pm
achv
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/2
04:16 pm
achv
Achieve Life Sciences Announces Granting of New Hire Inducement Awards [Yahoo! Finance]
Low
Report
Achieve Life Sciences Announces Granting of New Hire Inducement Awards [Yahoo! Finance]
10/2
04:01 pm
achv
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
Low
Report
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
9/30
10:40 am
achv
Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now [Seeking Alpha]
Low
Report
Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now [Seeking Alpha]